Date: 2015-09-08
Type of information: Nomination
Compound:
Company: Threshold Pharmaceuticals (USA - CA)
Therapeutic area: Cancer - Oncology
Type agreement: nomination
Action mechanism:
Disease:
Details: * On September 8, 2015, Threshold Pharmaceuticals announced the appointment of Mark Hopkins , J.D., Ph.D., as Vice President of Intellectual Property and Assistant General Counsel. In this newly created position, Dr. Hopkins will oversee worldwide intellectual property strategy and activities related to further advancement of Threshold's intellectual property portfolio for its investigational anti-cancer therapeutics, evofosfamide and tarloxotinib bromide, and hypoxia-activated prodrug technology. Dr. Hopkins will also be responsible for oversight of corporate legal matters at Threshold. Dr. Hopkins joins Threshold with more than 16 years of legal experience in the pharmaceutical industry. Prior to joining Threshold, Dr. Hopkins was a partner at Kilpatrick Townsend and Stockton LLP where he led a team of legal professionals providing legal opinions and securing patents for pharmaceutical companies on their key drugs and technologies.
Financial terms:
Latest news:
